BKSY vs LMB

The Advanced Deterministic Scorecard reveals severe financial health concerns with a Piotroski F-Score of just 1/9, indicating weak operational and balance sheet fundamentals. Despite strong gross margins and recent revenue beat trends, the company is deeply unprofitable with negative earnings, deteriorating margins, and a high debt/equity ratio. Insider selling activity, declining YoY revenue, and stretched valuation metrics further undermine confidence. While the stock has rallied 126.8% over the past year, fundamentals do not support this appreciation, raising sustainability concerns.

LMB exhibits strong financial health with a Piotroski F-Score of 7/9 and a conservative Debt/Equity ratio of 0.29. While the current price of $82.59 is significantly above the Graham Number ($34.97), it trades below the growth-based intrinsic value of $95.28 and well below the analyst target of $116.60. The company demonstrates exceptional growth momentum with 30.1% YoY revenue growth and a remarkable 25-quarter track record of earnings surprises. Despite bearish insider selling and a weak technical trend, the fundamental trajectory and profitability metrics support a bullish outlook.